Robert Preissner at Charité – University Medicine Berlin - Research Interests, Publications & Academic Profile

Robert Preissner

University Name

Germany

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

80%

Pharmacology

50%

Oral Cancer

40%

Drug Safety

40%

Covid-19

30%

Cancer Therapy

30%

Drug Repurposing

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles18

Beneficial Effect of Metformin on the Five-Year Survival in about 40,000 Patients with Head and Neck Cancer

Article Link

Year:

2024

ProTox 3.0: a webserver for the prediction of toxicity of chemicals

Article Link

Year:

2024

Association of Herpes simplex infection with significantly increased risk of head and neck cancer: real‐world evidence of about 500,000 patients

Article Link

Year:

2024

Withdrawn 2.0—update on withdrawn drugs with pharmacovigilance data

Article Link

Year:

2024

Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study.

Article Link

Year:

2024

Non-animal models for blood-brain barrier permeability evaluation of drug-like compounds.

Article Link

Year:

2024

Rosacea is strongly associated with melanoma in Caucasians.

Article Link

Year:

2024

DRD2, DRD3, and HTR2A Single-Nucleotide Polymorphisms Involvement in High Treatment Resistance to Atypical Antipsychotic Drugs

Article Link

Year:

2023

Cystic fibrosis transmembrane conductance regulator modulators attenuate platelet activation and aggregation in blood of healthy donors and COVID-19 patients.

Article Link

Year:

2023

The Impact of Drug–Drug Interactions on the Toxicity Profile of Combined Treatment with BRAF and MEK Inhibitors in Patients with BRAF-Mutated Metastatic Melanoma

Article Link

Year:

2023

A retrospective case-control study for the comparison of 5-year survival rates: the role of adjuvant and neoadjuvant chemotherapy in craniofacial bone sarcoma in adults.

Article Link

Year:

2023

Statin Medication Improves Five-Year Survival Rates in Patients with Head and Neck Cancer: A Retrospective Case-Control Study of about 100,000 Patients

Article Link

Year:

2023

Antibiotics Significantly Decrease the Survival of Head and Neck Carcinoma Patients with Immunotherapy: A Real-World Analysis of More Than 3000 Cases

Article Link

Year:

2023

Increased incidence of adult-onset Still's disease in association with COVID-19 vaccination and SARS-CoV-2 infection.

Article Link

Year:

2023

Using real-world evidence data and digital monitoring to analyze the hepatotoxic profiles of biologics across more than two million patients.

Article Link

Year:

2023

A Comparative Analysis of COVID-19 Vaccines Based on over 580,000 Cases from the Vaccination Adverse Event Reporting System

Article Link

Year:

2022

Analysis of the Risk of Oral Squamous Cell Carcinoma in Patients with and without Recurrent Aphthous Stomatitis: A Retrospective Evaluation of Real-World Data of about 150,000 Patients

Article Link

Year:

2022

Onset of Oral Lichenoid Lesions and Oral Lichen Planus Following COVID-19 Vaccination: A Retrospective Analysis of about 300,000 Vaccinated Patients

Article Link

Year:

2022

Collaborators13

Felix Behrens

Charité - Universitätsmedizin Berlin

GERMANY

Susanne Nahles

Charité - Universitätsmedizin Berlin

GERMANY

Carsten Rendenbach

Charité - Universitätsmedizin Berlin

GERMANY

Marina BORRO

Associate Professor - Biochemistry

Sapienza University of Rome

ITALY

Renata Abel

Charité - Universitätsmedizin Berlin

GERMANY

Philip Bourne

University of Virginia

UNITED STATES

Saskia Preissner

GERMANY

Paolo Marchetti

Sapienza University of Rome

ITALY

Robert Szulcek

Assoc. Prof. (W2)

Charité - Universitätsmedizin Berlin

GERMANY

Jonas Wüster

GERMANY

Maurizio Pompili

Sapienza University of Rome

ITALY

Silvia MEZI

Aggregate professor

Sapienza University of Rome

ITALY

Antonio Del Casale

Associate Professor

Sapienza University of Rome

ITALY

How do I reach out?

Meet Kite AI